Veeva Systems reported Q2 2026 revenue of $789 million, raising full-year billings guidance by $35 million. The company has resolved restrictions with IQVIA, enabling an integrated commercial suite, and accelerated Vault CRM adoption among top-20 pharmaceutical customers. Veeva now counts nine committed top-20 CRM customers, compared to three for Salesforce.
Veeva Systems Inc. (NYSE: VEEV) announced its Q2 2026 financial results on August 27, 2025, reporting total revenue of $789 million, a 17% year-over-year increase. The company also raised its full-year billings guidance by $35 million, reflecting a robust performance in the life sciences cloud software sector. Veeva's stock closed at $286.54, rising 2.61% on the day and continuing to climb 1.19% in after-hours trading, signaling positive market reception to the results.
Key highlights of the quarter include:
- Revenue Growth: Total revenue reached $789 million, up 17% year-over-year from $676 million in Q2 2025. Subscription revenue grew 18% to $659 million, while services revenue increased by 13% to $130 million.
- Operating Margins: Non-GAAP operating income reached $353 million, up 26% from $280 million in the same period last year, resulting in a non-GAAP operating margin of 44.7%.
- CRM Adoption: Veeva resolved restrictions with IQVIA, enabling an integrated commercial suite. The company also accelerated Vault CRM adoption among top-20 pharmaceutical customers, now counting nine committed top-20 CRM customers compared to three for Salesforce.
Looking ahead, Veeva expects total revenue between $3,134-3,140 million for the full fiscal year 2026, representing approximately 14% year-over-year growth. Non-GAAP operating income is projected to be approximately $1,388 million, with non-GAAP earnings per share of around $7.78.
Veeva's strategic initiatives, such as the standardization of Termination for Convenience (TFC) rights for customers with multi-year ramping deals, demonstrate a commitment to longer-term contract durations and stronger customer relationships.
The positive market reaction to these results suggests investors are confident in Veeva's ability to deliver on its growth targets and financial projections for the remainder of fiscal year 2026 and beyond.
References:
[1] https://www.investing.com/news/company-news/veeva-systems-q2-2026-slides-revenue-up-17-operating-margins-expand-93CH-4213306
[2] https://www.nasdaq.com/articles/veeva-systems-lifts-outlook-crm-wins
Comments
No comments yet